4:51 PM
 | 
Jul 16, 2013
 |  BC Extra  |  Top Story

FDA to review Iroko's Tiforbex

Iroko Pharmaceuticals LLC (Philadelphia, Pa.) said FDA accepted for review an NDA for Tiforbex submicron indomethacin to treat...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >